|Last Update: 05/20/13 - 11:48 AM EDT|
|YTD Performance: 12.49%|
|Previous Close: $98.00|
|52 Week Range: $74.12 - $98.99|
|Oustanding Shares: 85,687,806|
|Market Cap: 8,317,715,328|
|Qtr (06/13)||Qtr (09/13)||FY (12/13)||FY (12/14)|
|Number of Analysts||11||11||12||13|
|Growth Rate (Year over Year)||3.57%||8.01%||5.97%||12.13%|
WAT was downgraded from Overweight to Neutral, JP Morgan said. Company is operating near peak margins and may face increased competition.
WAT was downgraded from Outperform to Market Perform, Leerink Swann said. Company may struggle to exceed consensus earnings expectations.
Dividends did not rule in 2012.
Shares of WAT now seen reaching $89, according to Morgan Stanley. Estimates also reduced, given the company's new guidance. Overweight rating.
The low P/E ratio here simply doesn’t square with this company’s rock-solid fundamentals.
WAT was upgraded from Neutral to Buy, Mizuho said. $92 price target. Company has strong exposure to Asia.
Shares of WAT now seen reaching $96, according to Morgan Stanley. Estimates also reduced, as the company is seeing lower organic growth. Overweight rating.
WAT was upgraded from Neutral to Overweight, JP Morgan said. $90 pirce tagret. Company can continue to gain market share, despite exposure to Europe.
Coverage of WAT was started with a Buy rating, Cantor Fitzgerald said. $86 price target. Company can continue to expand market share and margins.
WAT was initiated with a Neutral rating, Credit Suisse said. Valuation call, based on an $80 price target.